PWPS
NGNE icon

Pinnacle Wealth Planning Services’s Neurogene NGNE Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-715
Closed -$69K – 468
2021
Q4 		$69K Buy
+715
New +$87.1K 0.01% 410

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Pinnacle Wealth Planning Services's NGNE Position: Q1 2022 in Review

Pinnacle Wealth Planning Services sold out of Neurogene (NGNE) in Q1 2022, closing a stake of 715 shares — an estimated $69K sold.

Pinnacle Wealth Planning Services first reported a position in NGNE in Q4 2021 and held it in 1 quarter. The position peaked at $69K in Q4 2021. 81 funds tracked by Wall St. Rank hold NGNE as of Q1 2022.

  • Pinnacle Wealth Planning Services reported no remaining Neurogene position as of Q1 2022 after selling out during the quarter.
  • Pinnacle Wealth Planning Services sold 715 Neurogene shares in Q1 2022, an estimated $69K.
  • Pinnacle Wealth Planning Services first reported a position in Neurogene in Q4 2021 and held it in 1 quarter.
  • Pinnacle Wealth Planning Services's Neurogene position peaked at $69K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Neurogene as of Q1 2022.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2022, filed 20 Apr 2022.